FGF23 and bone disorder: This results in low circulatory calcitriol that causes hyperphosphatemia and elevated fibroblast growth factor-23 (FGF-23) concentrations [45]; these initiate the CKD of mineral and bone disorder (CKD-MBD) [46,47].